Clinical Trial Update: Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating SHR117887 in combination with Metformin for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR117887
• metformin (metformin)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED